August 05, 2021 + Jessica Di Palo
3 Min read
Are you new to the healthtech space? Maybe even the investment sector? Was that a “Yes”? Don’t worry, in the beginning, everything seems overwhelming and all the definitions and keywords are tricky to keep in mind. But there is always hope…
It happens every day that the investment sector, or specifically the private equity sector, finds new prospects or new investors in fundraising processes. Private Equity and Venture Capital are sometimes not even established in some countries or regions.
Our job is to deploy capital and help companies operating in the healthtech sector grow. How? By investing in them and selling our shares when the time is right. Sounds easy? If you sum it up like this of course it does. But there is more to it and we are happy to show you. To give you a little guidance on how to correctly understand some terms used on our website, we want to offer you a glossary in this blog post.
Let’s start and dive into the (private equity) business…
An acquisition is the process of one company purchasing most or all of another company’s shares. In the end, the control of the company is transferred from the original company (or companies) to the new owner. If more than 50% of a target firm’s shares were bought the new owner can take decisions without consulting or the approval of the other shareholders.
Angel investors are individuals who provide a certain amount of capital to a startup for a stake in the company. This usually happens when the startup is in its infancy. Angel Investors can offer guidance and sometimes even serve as mentors to these startups.
This is a group of influential individuals, elected by stockholders, chosen to oversee the affairs of a company. A board typically includes investors and mentors. Not all companies have a board, but investors typically require a board seat in exchange for an investment in a company. The board of directors is an entity that meets regularly. You can meet our board of directors here.
A buyout describes a common exit strategy. It involves the purchase of a firm’s shares and with that, the buyer receives a controlling interest in the company.
ESG is short for environmental, social, and governance. These are a set of criteria and standards for a company’s operations that investors use to screen potential investments. These investors, MTIP included, focus on social responsibility and ESG guidelines to help them analyze the potential of a company. The environmental criteria evaluate if the company takes the right measures to preserve nature. Examples of the social part are how the company manages interactions and relations with its customers, its own employees, or its suppliers. The governance part covers leadership aspects, executive pay, shareholder rights, and much more.
We have been using these standards to analyze potential and current portfolio companies for many years. Here you can learn more about ESG at MTIP.
An exit is the process of selling a stake in a company that has been acquired in the past. Of course, the target is always to make a profit by selling the shares of a company. Unfortunately, this is not always the case.
A fund is a pool of money that is allocated for a specific purpose. A fund can be established for many different purposes: a city government setting aside money to build a new park or a foundation setting aside money to award scholarships. In private equity funds are used to invest in companies and create a portfolio.
We at MTIP currently manage two funds. The purpose of these two funds is to invest in companies that we define as healthtech champions. Learn more about us here.
In private equity, the General Partner (or short GP), refers to the private equity company that supervises a PE (private equity) fund. The third-party investors that are acquired through a fundraising process are the limited partners (LP). The GP is responsible for operating the fund, deal sourcing, and investing as well as exiting invested companies and assisting the portfolio companies to help them grow.
Growth refers to an investment approach and strategy, which focuses on increasing an investor’s capital. These investors typically invest in growth stocks from young and small companies. The earnings of these companies are expected to get higher and higher- exceeding the average rate (in comparison to their overall market).
Healthtech is the fastest-growing vertical within the healthcare sector. It includes any technology-enabled healthcare product and service that can be delivered or consumed outside of a hospital or physician’s office.
MTIP’s investment strategy focuses on healthtech in all its varieties. With companies like Oviva, Trialbee, and Koa Health we have already made 3 investments with our second fund. Every investment is unique and covers a specific niche. Have a look at our portfolio companies.
The holding period is the time frame between the acquisition and the exit of a portfolio company.
That is what we are! A company or a person (e.g. angel investor), that invests capital with the intent to receive financial returns.
Companies that are defined as “later-stage” are no startups anymore. These companies have established themselves in their specific market sector and usually, the invested capital can be converted faster into returns.
You’ve already heard about the general partner (GP) in this glossary and now comes the limited partner (LP). Basically: Two or more partners form a limited partnership. When we at MTIP talk about LP’s we mean our limited partners that invested in our funds.
This term refers to funds that invest and restructure companies that are not (yet) publicly traded.
Digital Health is a subcategory of healthtech. The broader scope of digital health includes categories such as mobile health (mHealth), health information technology (IT), wearable devices, telehealth and telemedicine, and personalized medicine.
With patient-centric, we describe the process of “Putting the patient first in an open and sustained engagement of the patient to respectfully and compassionately achieve the best experience and outcome for that person and their family” (Yeoman G. et al. BMJ Innov. 2017;0.1-8).
Instead of primarily focusing on maximizing profits, the term “social responsibility” adds society into the equation. Meaning that the actions of a company must benefit society. This term has become more and more important among investors and consumers since climate change and social issues are dominating the news nowadays. We at MTIP take social responsibility very seriously. Take a look at our investment approach and how we incorporate social responsibility into our strategy.
For us teamwork means everything. As a company, we celebrate working together in every aspect of our daily business. We also partner up with our portfolio companies to lead them to success. Have a look at our amazing portfolio.
In the next 101, we will deliver you more insights into our daily work!
SFDR Art. 8 or Art. 9? What’s the difference?
SFDR: getting the terminology right
MTIP participates in Oviva’s new $80m Series C funding
Oviva raises $80 million financing round
MTIP invests in Intelligencia to reduce the risk of clinical research through artificial intelligence
MTIP's new investment in Intelligencia
Private Equity 101: Part one – Glossary
Are you new to the healthtech space?
Leading brands revolutionize care journeys with Lumeon
How Lumeon orchestrates care journey
Trialbee – our hero in patient matching and recruiting for clinical trials
Trialbee - patient matching and recruiting
Digital healthcare: patient-first?
Digital Healthcare Report 2021 in collaboration with Dealroom and INKEF Capital
SFDR – How does MTIP approach the EU’s Sustainable Disclosure Regulation?
New SFDR obligations
MTIP Announces Strong First Closing of Fund II to drive Healthtech Innovation
First Closing of Fund II
How to pitch to a healthtech Investor
MTIP invests in Koa Health to make mental health treatment more accessible
New investment in Koa Health
MTIP scored fantastic grades in the UNPRI assessment report of 2020
UNPRI Report grades 2020
4 Health VCs Share Their Business Priorities and What is Next
MTIP invests in Trialbee
New investment in Trialbee
TytoCare closes $50 million round as the demand for telehealth accelerates
TytoCare closes new round
The digital healthtech sector is expanding – and so are we!
Two new empolyees start in April
MTIP has sucessfully exited Blueprint Genetics
Blueprint exit January 2020
New MTIP investment in Oviva
New investment in Oviva
Whitepaper: A positive prognosis for the future of healthtech
Our first Whitepaper
Elite Summit 2019 – Interview with our Managing Partner Christoph Kausch
Elite Summit 2019
MTIP Healthcare Clinic 2019
Healthcare clinic 2019
New MTIP investment in Cynerio
New investment in Cynerio
MTIP invests in Lumeon Ltd.
New investment in Lumeon
Magenverkleinerung mit der Handnähmaschine
Nitinotes news paper article
New MTIP investment in Quanta Dialysis Technologies
New investment in Quanta